Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMC 4643961)

Published in PLoS One on November 13, 2015

Authors

Daxing Xie1,2, Liang Liu1,2, Hasan Osaiweran1,2, Chaoran Yu1,2, Fang Sheng1,2, Chun Gao1,2, Junbo Hu1,2, Jianping Gong1,2

Author Affiliations

1: Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.
2: Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.

Associated clinical trials:

Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision(D2+CME)for Advanced Gastric Cancer | NCT01978444

Articles cited by this

Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99

The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg (1982) 8.69

Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis (2009) 5.72

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci U S A (2010) 2.16

Mesogastrium: a fifth route of metastasis in gastric cancer? Med Hypotheses (2013) 1.72

A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc (2005) 1.59

Biologic predictors of survival in node-negative gastric cancer. Ann Surg (2003) 1.37

Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum (1998) 1.19

Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol (2000) 1.16

Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma. Br J Surg (2006) 1.12

Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol (2008) 1.05

Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis (2004) 0.99

Systemic treatment of gastric cancer. Eur J Gastroenterol Hepatol (2004) 0.98

Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Surgery (2005) 0.90

Is timing of death from tumor recurrence predictable after curative resection for gastric cancer? World J Surg (2001) 0.89

Perinodal involvement of cancer cells in gastric cancer patients. Surgery (2004) 0.88

Mesogastrium recurrence as expression of the fifth metastatic route of gastric cancer. Med Hypotheses (2014) 0.85

Microscopic cancer cell spread in gastric cancer: whole-section analysis of mesogastrium. Langenbecks Arch Surg (2008) 0.81